Genetic Variants at the Nebulette Locus Are Associated with Myxomatous Mitral Valve Disease Severity in Cavalier King Charles Spaniels

Overview

Journal Genes (Basel)

Publisher MDPI

Date 2022 Dec 23

PMID 36553559

Authors

Sophie E Mead

Niek J Beijerink

Mitchell OBrien

Claire M Wade

Affiliations

Soon will be listed here.

Abstract

The most common cardiovascular disease in domestic dogs is myxomatous mitral valve disease (MMVD), accounting for 75% of all cardiac disease. An increase in age is generally associated with increased incidence of the disease, but Cavalier King Charles Spaniels (CKCS) exhibit an unusually high prevalence of early-onset MMVD, and thus, potentially greater cardiac morbidity and mortality compared to other breeds. Previous research has suggested that selected candidate risk alleles for MMVD are fixed in CKCSs, including six locations within the () gene on CFA2. The current study analysed genotypes of 180 Australian CKCSs at the identified risk loci. Of these, 178 were phenotyped for severity of disease by echocardiographic measurements of left atrium to aortic root ratio (LA:Ao) and weight normalised left ventricular end diastolic diameter (LVIDdN). Genotyping array markers correctly predicted the genotype at the risk-variant loci in the CKCS population, and the , and variants were observed to be in perfect linkage disequilibrium in this cohort. The CKCS cohort included 6/178 dogs being heterozygous for the protective/wild-type alleles at the NEBL locus. The mean LA:Ao and LVIDdN scores of these dogs heterozygous at variants were significantly smaller, and with significantly lower variance compared to age-matched CKCSs that were homozygous for risk alleles. The lower cardiac measurements in the heterozygous dogs indicate a significantly reduced risk of severe MMVD disease. Our analysis suggests that despite relative fixation of the NEBL risk alleles, healthy reference alleles at exist in low frequency in the CKCS breed and can be used to reduce MMVD severity and mortality.

References

Jung S, Bohan A . Genome-wide sequencing and quantification of circulating microRNAs for dogs with congestive heart failure secondary to myxomatous mitral valve degeneration. Am J Vet Res. 2018; 79(2):163-169. DOI: 10.2460/ajvr.79.2.163. View

Markby G, MacRae V, Corcoran B, Summers K . Comparative transcriptomic profiling of myxomatous mitral valve disease in the cavalier King Charles spaniel. BMC Vet Res. 2020; 16(1):350. PMC: 7509937. DOI: 10.1186/s12917-020-02542-w. View

Bionda A, Cortellari M, Bagardi M, Frattini S, Negro A, Locatelli C . A Genomic Study of Myxomatous Mitral Valve Disease in Cavalier King Charles Spaniels. Animals (Basel). 2020; 10(10). PMC: 7602727. DOI: 10.3390/ani10101895. View

Borgarelli M, Savarino P, Crosara S, Santilli R, Chiavegato D, Poggi M . Survival characteristics and prognostic variables of dogs with mitral regurgitation attributable to myxomatous valve disease. J Vet Intern Med. 2008; 22(1):120-8. DOI: 10.1111/j.1939-1676.2007.0008.x. View

Ancot F, Lemay P, Knowler S, Kennedy K, Griffiths S, Cherubini G . A genome-wide association study identifies candidate loci associated to syringomyelia secondary to Chiari-like malformation in Cavalier King Charles Spaniels. BMC Genet. 2018; 19(1):16. PMC: 5865342. DOI: 10.1186/s12863-018-0605-z. View

Keene B, Atkins C, Bonagura J, Fox P, Haggstrom J, Luis Fuentes V . ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs. J Vet Intern Med. 2019; 33(3):1127-1140. PMC: 6524084. DOI: 10.1111/jvim.15488. View

Axelsson E, Ljungvall I, Bhoumik P, Bas Conn L, Muren E, Ohlsson A . The genetic consequences of dog breed formation-Accumulation of deleterious genetic variation and fixation of mutations associated with myxomatous mitral valve disease in cavalier King Charles spaniels. PLoS Genet. 2021; 17(9):e1009726. PMC: 8412370. DOI: 10.1371/journal.pgen.1009726. View

Lewis T, Swift S, Woolliams J, Blott S . Heritability of premature mitral valve disease in Cavalier King Charles spaniels. Vet J. 2010; 188(1):73-6. DOI: 10.1016/j.tvjl.2010.02.016. View

Jagannathan V, Drogemuller C, Leeb T . A comprehensive biomedical variant catalogue based on whole genome sequences of 582 dogs and eight wolves. Anim Genet. 2019; 50(6):695-704. PMC: 6842318. DOI: 10.1111/age.12834. View

10.

French A, Ogden R, Eland C, Hemani G, Pong-Wong R, Corcoran B . Genome-wide analysis of mitral valve disease in Cavalier King Charles Spaniels. Vet J. 2011; 193(1):283-6. DOI: 10.1016/j.tvjl.2011.09.011. View

11.

Swenson L, Haggstrom J, Kvart C, Juneja R . Relationship between parental cardiac status in Cavalier King Charles spaniels and prevalence and severity of chronic valvular disease in offspring. J Am Vet Med Assoc. 1996; 208(12):2009-12. View

12.

Oyama M, Elliott C, Loughran K, Kossar A, Castillero E, Levy R . Comparative pathology of human and canine myxomatous mitral valve degeneration: 5HT and TGF-β mechanisms. Cardiovasc Pathol. 2020; 46:107196. PMC: 7078050. DOI: 10.1016/j.carpath.2019.107196. View

13.

Madsen M, Olsen L, Haggstrom J, Hoglund K, Ljungvall I, Falk T . Identification of 2 loci associated with development of myxomatous mitral valve disease in Cavalier King Charles Spaniels. J Hered. 2011; 102 Suppl 1:S62-7. DOI: 10.1093/jhered/esr041. View

14.

Borgarelli M, Buchanan J . Historical review, epidemiology and natural history of degenerative mitral valve disease. J Vet Cardiol. 2012; 14(1):93-101. DOI: 10.1016/j.jvc.2012.01.011. View

15.

Fox P . Pathology of myxomatous mitral valve disease in the dog. J Vet Cardiol. 2012; 14(1):103-26. DOI: 10.1016/j.jvc.2012.02.001. View

16.

Perrot A, Tomasov P, Villard E, Faludi R, Melacini P, Lossie J . Mutations in NEBL encoding the cardiac Z-disk protein nebulette are associated with various cardiomyopathies. Arch Med Sci. 2016; 12(2):263-78. PMC: 4848357. DOI: 10.5114/aoms.2016.59250. View

17.

Maiellaro-Rafferty K, Wansapura J, Mendsaikhan U, Osinska H, James J, Taylor M . Altered regional cardiac wall mechanics are associated with differential cardiomyocyte calcium handling due to nebulette mutations in preclinical inherited dilated cardiomyopathy. J Mol Cell Cardiol. 2013; 60:151-60. PMC: 3683841. DOI: 10.1016/j.yjmcc.2013.04.021. View

18.

Lu C, Liu M, Culshaw G, Clinton M, Argyle D, Corcoran B . Gene network and canonical pathway analysis in canine myxomatous mitral valve disease: a microarray study. Vet J. 2015; 204(1):23-31. DOI: 10.1016/j.tvjl.2015.02.021. View

19.

Chang C, Chow C, Tellier L, Vattikuti S, Purcell S, Lee J . Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience. 2015; 4:7. PMC: 4342193. DOI: 10.1186/s13742-015-0047-8. View

20.

Purevjav E, Varela J, Morgado M, Kearney D, Li H, Taylor M . Nebulette mutations are associated with dilated cardiomyopathy and endocardial fibroelastosis. J Am Coll Cardiol. 2010; 56(18):1493-502. PMC: 2957670. DOI: 10.1016/j.jacc.2010.05.045. View